$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

$cpsh Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000143774922019137 Filed on August 05, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue	$7.071M	$6.653M	$6.206M
YoY Change	28.21%	13.49%	49.55%
Cost Of Revenue	$5.242M	$4.689M	$4.852M
YoY Change	19.8%	3.96%	32.92%
Gross Profit	$1.829M	$1.963M	$1.355M
YoY Change	60.52%	45.27%	170.96%
Gross Profit Margin	25.86%	29.51%	21.83%
Selling, General & Admin	$1.159M	$1.416M	$1.042M
YoY Change	-5.55%	28.92%	31.95%
% of Gross Profit	63.39%	72.14%	76.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$105.1K	$57.87K
YoY Change	-100.0%	-21.79%	-61.42%
% of Gross Profit	0.0%	5.35%	4.27%
Operating Expenses	$1.159M	$1.416M	$1.042M
YoY Change	-5.55%	28.93%	31.95%
Operating Profit	$669.5K	$547.1K	$312.4K
YoY Change	-860.24%	116.27%	-207.72%
Interest Expense	$1.590K	-$2.270K	$28.71K
YoY Change	-160.46%	-83.51%	-195.7%
% of Operating Profit	0.24%	-0.41%	9.19%
Other Income/Expense, Net		$360.00	-$30.73K
YoY Change			-134.14%
Pretax Income	$671.1K	$545.2K	$310.4K
YoY Change	-1031.66%	127.92%	-234.94%
Income Tax	$216.0K	$125.8K	$92.56K
% Of Pretax Income	32.18%	23.07%	29.82%
Net Earnings	$455.1K	$419.4K	$217.8K
YoY Change	-83.32%	75.35%	-199.0%
Net Earnings / Revenue	6.44%	6.3%	3.51%
Basic Earnings Per Share	$0.03
Diluted Earnings Per Share	$0.03	$28.62K	$14.78K
COMMON SHARES
Basic Shares Outstanding	14.43M	14.43M	14.35M
Diluted Shares Outstanding	14.71M

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.076M	$4.700M	$5.050M
YoY Change	32.27%	55.84%	2425.16%
Cash & Equivalents	$5.076M	$4.700M	$5.050M
Short-Term Investments
Other Short-Term Assets	$313.5K	$335.0K	$225.9K
YoY Change	136.93%	22.46%	222.67%
Inventory	$4.666M	$4.706M	$3.912M
Prepaid Expenses
Receivables	$4.537M	$4.903M	$4.870M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$14.59M	$14.64M	$14.06M
YoY Change	14.22%	25.03%	104.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.413M	$1.322M	$1.333M
YoY Change	20.22%	-26.97%	3.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.483M	$2.699M	$2.824M
YoY Change	-14.62%	2206.57%	2253.32%
Total Long-Term Assets	$4.424M	$4.579M	$4.743M
YoY Change	-5.8%	137.53%	231.68%
TOTAL ASSETS
Total Short-Term Assets	$14.59M	$14.64M	$14.06M
Total Long-Term Assets	$4.424M	$4.579M	$4.743M
Total Assets	$19.02M	$19.22M	$18.80M
YoY Change	8.84%	40.93%	125.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.621M	$1.621M	$2.100M
YoY Change	-4.58%	6.5%	130.98%
Accrued Expenses	$805.2K	$648.2K	$1.086M
YoY Change	-10.75%	-43.58%	35.11%
Deferred Revenue		$1.753M	$1.707M
YoY Change			13919.36%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$47.32K	$51.62K	$55.91K
YoY Change	5.58%	-13.16%	-6.82%
Total Short-Term Liabilities	$4.226M	$4.226M	$5.105M
YoY Change	7.0%	34.97%	182.23%
LONG-TERM LIABILITIES
Long-Term Debt	$77.12K	$87.99K	$98.68K
YoY Change	-38.09%	-29.37%	-34.21%
Other Long-Term Liabilities	$371.0K	$401.0K	$431.0K
YoY Change	-19.35%	-17.66%
Total Long-Term Liabilities	$448.1K	$489.0K	$529.7K
YoY Change	-23.34%	-20.04%	253.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.226M	$4.226M	$5.105M
Total Long-Term Liabilities	$448.1K	$489.0K	$529.7K
Total Liabilities	$4.674M	$4.674M	$5.634M
YoY Change	3.09%	24.89%	186.99%
SHAREHOLDERS EQUITY
Retained Earnings		-$25.38M	-$26.26M
YoY Change			-10.91%
Common Stock		$144.4K	$143.5K
YoY Change			4.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$20.85K	$2.515K
YoY Change			-99.75%
Treasury Stock Shares		$4.318K	$335.00
Shareholders Equity	$14.34M	$13.85M	$13.17M
YoY Change
Total Liabilities & Shareholders Equity	$19.02M	$19.02M	$18.80M
YoY Change	8.84%	39.43%	125.95%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	$455.1K	$419.4K	$217.8K
YoY Change	-83.32%	75.35%	-199.0%
Depreciation, Depletion And Amortization	$0.00	$105.1K	$57.87K
YoY Change	-100.0%	-21.79%	-61.42%
Cash From Operating Activities	$0.00	-$379.3K	$1.458M
YoY Change	-100.0%	-859.15%	47.26%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$94.68K	-$215.6K
YoY Change	-100.0%	-23.35%	618.53%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$0.00	-$94.68K	-$215.6K
YoY Change	-100.0%	-29.09%	618.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	123.3K	-29.75K
YoY Change	-100.0%	-95.78%	-96.58%
NET CHANGE
Cash From Operating Activities	0.000	-379.3K	1.458M
Cash From Investing Activities	0.000	-94.68K	-215.6K
Cash From Financing Activities	0.000	123.3K	-29.75K
Net Change In Cash	0.000	-350.6K	1.213M
YoY Change	-100.0%	-112.34%	1247.29%
FREE CASH FLOW
Cash From Operating Activities	$0.00	-$379.3K	$1.458M
Capital Expenditures	$0.00	-$94.68K	-$215.6K
Free Cash Flow	$0.00	-$284.6K	$1.673M
YoY Change	-100.0%	-264.05%	64.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-25
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14436786
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14350786
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14434468
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14350451
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	4318
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	335
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-319	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-07-02
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-16088
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2832509
	dei	Entity Address Address Line1 EntityAddressAddressLine1	111 South Worcester Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Norton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02766-2102
	dei	City Area Code CityAreaCode	508
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Local Phone Number LocalPhoneNumber	222-0614
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Trading Symbol TradingSymbol	CPSH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14433509
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5076282	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5050312	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4536973	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4870021	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	4665719	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	3911602	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	313501	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	225873	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	14592475	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	14057808	usd
CY2022Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10545236	usd
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10489729	usd
CY2022Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	738205	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	673305	usd
CY2022Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	968509	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	951384	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12251950	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12114418	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11212803	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11028154	usd
CY2022Q3	cpsh	Construction In Progress Net ConstructionInProgressNet	373776	usd
CY2021Q4	cpsh	Construction In Progress Net ConstructionInProgressNet	246669	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1412923	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1332933	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	528000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	586000	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2482720	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2823978	usd
CY2022Q3	us-gaap	Assets Assets	19016118	usd
CY2021Q4	us-gaap	Assets Assets	18800719	usd
CY2022Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	47321	usd
CY2021Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	55906	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1621278	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2100251	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	648180	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1086429	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1752543	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1707138	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	157000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	155000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4226322	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5104724	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	77120	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	98684	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	371000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	431000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	4674442	usd
CY2021Q4	us-gaap	Liabilities Liabilities	5634408	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	144388	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	143508	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39600085	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39281810	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25381948	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26256492	usd
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	20849	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2515	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	14341676	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13166311	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19016118	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18800719	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7070743	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5862183	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13723457	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10727890	usd
CY2022Q3	us-gaap	Revenues Revenues	7070743	usd
CY2021Q2	us-gaap	Revenues Revenues	5862183	usd
	us-gaap	Revenues Revenues	13723457	usd
	us-gaap	Revenues Revenues	10727890	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5242106	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4510600	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9931330	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8432168	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1828637	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	1351583	usd
	us-gaap	Gross Profit GrossProfit	3792127	usd
	us-gaap	Gross Profit GrossProfit	2295722	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1159157	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1098616	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2575550	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2007086	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	669480	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	252967	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1216577	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	288636	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1594	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-13769	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18079	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	671074	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	239198	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1216258	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	270557	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	215966	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	341714	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	456	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	455108	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	239198	usd
	us-gaap	Net Income Loss NetIncomeLoss	874544	usd
	us-gaap	Net Income Loss NetIncomeLoss	270101	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14431825
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13982177
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14410064
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13783276
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14708646
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14550918
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14682516
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14407904
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13848531	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39384	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8144	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6797	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	455108	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	14341676	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13166311	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	163855	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17758	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	154724	usd
	us-gaap	Net Income Loss NetIncomeLoss	874544	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	14341676	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	6426299	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92113	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3137392	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	919	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	239198	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	9895921	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6357664	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	119535	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3137392	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11229	usd
	us-gaap	Net Income Loss NetIncomeLoss	270101	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	9895921	usd
	us-gaap	Net Income Loss NetIncomeLoss	874544	usd
	us-gaap	Net Income Loss NetIncomeLoss	270101	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	211641	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	284408	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	163855	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	119535	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-333048	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1517511	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	754117	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	279963	usd
	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	87628	usd
	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	202018	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-478973	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	613046	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-438249	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	193665	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-341258	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	45405	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	388697	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	210784	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-130040	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	291631	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	163524	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-291631	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-163524	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	154724	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11229	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-17758	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3137392	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	30149	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	34500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	106817	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3114121	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	25970	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2820557	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5050312	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	195203	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5076282	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3015760	usd
	us-gaap	Interest Paid Net InterestPaidNet	4353	usd
	us-gaap	Interest Paid Net InterestPaidNet	18079	usd
	us-gaap	Stock Issued1 StockIssued1	18334	usd
	us-gaap	Stock Issued1 StockIssued1	24514	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	162000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	28000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	601000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	73000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	528000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	455108	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	239198	usd
	us-gaap	Net Income Loss NetIncomeLoss	874544	usd
	us-gaap	Net Income Loss NetIncomeLoss	270101	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14431825
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13982177
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14410064
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13783276
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	455108	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	239198	usd
	us-gaap	Net Income Loss NetIncomeLoss	874544	usd
	us-gaap	Net Income Loss NetIncomeLoss	270101	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14431825
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13982177
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14410064
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13783276
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	276821
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	568741
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	272452
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	624628
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14708646
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14550918
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14682516
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14407904
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q3	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	38000
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	81000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	157000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	371000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	528000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P44Y
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.066	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.41
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.81
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	15300
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	88000
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.44
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.97
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	16100
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	629900
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.58
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.97
CY2022Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3143
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3983
CY2021Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2235
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	122431
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	968100
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.41
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y5M15D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	517800
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.02
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M7D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1500000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	930800
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	616000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y11M12D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	39384	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	163855	usd
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	91113	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	119535	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	62474	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	79917	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	2691395	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2080778	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1447528	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1309572	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	704638	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	805159	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	4843561	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	4195509	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	177842	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	283907	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	4665719	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	3911602	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	460293	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	905698	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	125413	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	100814	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	648180	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1086429	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	25882	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	43837	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	46757	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	8090	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	124566	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	4353	usd
CY2022Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	215966	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	341258	usd

Files In Submission

Name	View Source	Status
0001437749-22-019137-index-headers.html	Edgar Link	pending
0001437749-22-019137-index.html	Edgar Link	pending
0001437749-22-019137.txt	Edgar Link	pending
0001437749-22-019137-xbrl.zip	Edgar Link	pending
cpsh-20220702.xsd	Edgar Link	pending
cpsh-20220702_cal.xml	Edgar Link	unprocessable
cpsh-20220702_def.xml	Edgar Link	unprocessable
cpsh-20220702_lab.xml	Edgar Link	unprocessable
cpsh-20220702_pre.xml	Edgar Link	unprocessable
cpsh20220702_10q.htm	Edgar Link	pending
cpsh20220702_10q_htm.xml	Edgar Link	completed
ex_406523.htm	Edgar Link	pending
ex_406524.htm	Edgar Link	pending
ex_406525.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2022 Q3 Form 10-Q Financial Statement

#000143774922019137 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2022 Q3 Form 10-Q Financial Statement

#000143774922019137 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh